Top Ten Cannabis Stocks
The green light is on. It’s “all systems go”, as far as the medical use of cannabis is concerned, at least in some parts of the world. The legalization of cannabis is a great thing for a great number of reasons, the most important being that it delivers hope to people who need the weed for medical reasons. People experiencing chronic pain, muscle spasm, lung problems, digestive issues, epilepsy, and cancer may now be able to access cannabis and benefit from its use.
On the financial side, legalizing cannabis brings about numerous economic benefits. The “Go “signal sparks an increase in the demand for cannabis, consequently opening up income opportunities of all sorts. The hype is up, indeed; the cannabis market is now growing by “leaps and bounds”, so to speak, and we can expect the market growth to continue moving north as more countries address restriction issues. Isn’t it just about time to get on the bandwagon yourself and put your money in the world’s top marijuana stocks 2018 before sales skyrocket?
Now, there are hundreds of marijuana stocks out there, and you probably don’t have the time to go through each one of them, so we’re shortlisting the ten biggest ones (in terms of market cap).
Here they are, your top marijuana stocks 2018 options:
- Canopy Growth Corp. (CGC)
Though listed on the NYSE only in May, Canopy Growth, a Canadian company, has become the largest publicly traded weed company with a market cap of $5.98B. A company that focuses on cannabis research, product development, and innovation, Canopy Growth has produced several well-known cannabis brands, the most popular of which is Tweed, which runs in partnership with celebrity rapper Snoop Dogg. The team-up has led to the meteoric rise in the CGC stocks value. Just last year, Constellation Brands, a big name in the beverage industry, bought a 9.9% stake in Canopy Growth. So what does this partnership tell us? Pretty soon, we’ll be tasting beverages infused with cannabis, that’s what!
- Aurora Cannabis
The second largest pot company is Aurora Cannabis with a market cap of $4.08B. Also a Canadian company, Aurora Cannabis recently engaged in an M&A with MedReleaf, and the partnership is seen to increase production of cannabis to as much as 570k kilos every year.
3. GW Pharmaceuticals
GW Pharmaceuticals has a market cap of $3.13 billion, and it is expected to rake in hundreds of millions of dollars in revenues now that its cannabidiol-based drug, Epidiolex, has finally earned FDA approval.
Aphria, a proud producer of 100% greenhouse-grown medical cannabis, has a market cap of $1.39 billion. It is working on a four-phase expansion project and partnership deal with Double Diamond Farms to give it the capability to produce 230k kilos of cannabis yearly.
- Cronos Group Inc. (CRON)
Cronos, also a Canadian cannabis producer, is the first weed company to migrate its trading operations from an OTC exchange to Nasdaq in February, earning the trust and confidence of many investors in the process. Its market cap has considerably grown to $1.15 B since then. Cronos is in a hundred-million-dollar deal with Ginkgo Bioworks Inc to produce lab-grown cannabis.
- Cara Therapeutics (CARA)
Cara Therapeutics is a biotechnology company that aims to develop products, such as opioid-based and cannabinoid-based drugs for the treatment of acute and chronic pain, and Pruritus. Its market cap is estimated at $630.1 M
7. HEXO Corp.
HEXO Corp., previously named Hydropothecary Corp, is a Quebec-based company, that has changed its corporate name in line with the development and launching of its new cannabis brand, HEXO, to cater to the adult-use cannabis market, this time. The company is working to expand its operations to increase production of cannabis to about 108k kilos a year. HEXO Corp. has a market cap of $504.3 million.
CannTrust is a pharmaceutical company that produces 100% pesticide-free Medical Cannabis. CannTrust is serving 40k actively registered patients and is set to increase its marketability with its expansion projects wherein it hopes to produce 40k kilos of cannabis annually. Its market cap is currently pegged at $473.2 million.
Auxly (formerly Cannabis Wheaton Income Corp) breaks into the top marijuana stocks 2018 list with a $442.2 million market cap. The change in name is said to be due to the company’s evolution into more than simply a streaming company.
- Emerald Health Therapeutics
Emerald Health, with a $416.3 million market cap, is working on a couple of things – a headquarters of its own in British Columbia and a partnership deal with Village Farms International. With these projects, Emerald Health hopes to produce 100k kilos of cannabis every year.
The cannabis market is looking good, but in spite of things pointing north, make sure to exercise prudence before putting your money in the right pot.
For more Cannabis Business Insights